Bank Of America Corp Relmada Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 13,716 shares of RLMD stock, worth $8,641. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,716

Previous 206,657 93.36%

Holding current value

$8,641

Previous $107,000 97.2%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.26 - $0.47 $50,164 - $90,682	-192,941 Reduced 93.36%	13,716 $3,000
Q4 2024 Feb 14, 2025	SELL	$0.35 - $3.65 $0 - $3	-1 Reduced -0.0%	206,657 $107,000
Q3 2024 Nov 14, 2024	SELL	$2.3 - $4.36 $3,015 - $5,715	-1,311 Reduced 0.63%	206,658 $669,000
Q2 2024 Aug 14, 2024	SELL	$2.93 - $4.94 $7,638 - $12,878	-2,607 Reduced 1.24%	207,969 $623,000
Q1 2024 May 15, 2024	SELL	$3.1 - $6.8 $170 - $374	-55 Reduced 0.03%	210,576 $979,000
Q4 2023 Feb 14, 2024	SELL	$2.45 - $4.22 $64,361 - $110,859	-26,270 Reduced 11.09%	210,631 $872,000
Q2 2023 Aug 14, 2023	BUY	$2.22 - $3.54 $443,038 - $706,467	199,567 Added 534.54%	236,901 $582,000
Q1 2023 May 12, 2023	BUY	$2.24 - $4.76 $46,533 - $98,884	20,774 Added 125.45%	37,334 $84,000
Q4 2022 Feb 10, 2023	BUY	$2.17 - $35.84 $5,848 - $96,588	2,695 Added 19.44%	16,560 $57,000
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $92,927 - $187,987	5,078 Added 57.79%	13,865 $513,000
Q2 2022 Aug 12, 2022	BUY	$16.5 - $30.34 $33,841 - $62,227	2,051 Added 30.45%	8,787 $166,000
Q1 2022 May 16, 2022	SELL	$16.72 - $26.99 $61,362 - $99,053	-3,670 Reduced 35.27%	6,736 $182,000
Q4 2021 Feb 08, 2022	SELL	$16.93 - $26.82 $31,743 - $50,287	-1,875 Reduced 15.27%	10,406 $235,000
Q3 2021 Nov 15, 2021	BUY	$21.86 - $34.77 $132,996 - $211,540	6,084 Added 98.18%	12,281 $322,000
Q2 2021 Sep 13, 2021	BUY	$29.55 - $39.15 $183,121 - $242,612	6,197 New	6,197 $199,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

6.3M

Call Options Held

Put Options Held

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $18M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Relmada Therapeutics, Inc. Transaction History